Project Results Sample Clauses

Project Results. The Results Report shall outline, in a manner to be provided by AMO, the degree to which investments in each project are supporting progress towards achieving revitalization within main street areas: a. Community Improvement Plan Eligible Projects • Number of small businesses supported; • Total value of physical improvements; • Total Main Street Funds provided; • Total Municipal investment; and, • Total private investment. b. Municipal Physical Infrastructure Eligible Projects

Project Results. For the purposes of the present agreement, the results of the project shall be considered to be any patents, other industrial and intellectual property rights, know-how and, in general, any information or material subject or otherwise to protection, created by each participant subsequent to the coming into force of the present agreement and in accordance with the project’s scientific-technical report.

Project Results any and all Institute-Funded Technology and Institute-Funded IPR.

Project Results. If a Project Order states that the Project Results are confidential, then the Project Results for that Approved Research Project are the Confidential Information of the party specified in the relevant Project Order to own Non-Derivative IP.

Project Results. The Project Results, meaning the outcomes and results of the Project, may comprise biological samples, data, intellectual property, materials, any Product and Investigational Product, publications, reference standards, technology and other results and shall include all Project IP, Project Data and Project Materials.

Project Results. (a) All Project Results created in relation to the Project, upon creation, vest in and will become and remain the property of Prana, only subject to Prana's contractual agreements with the University of Melbourne in relation to this Agreement. Prana is free to deal with, Commercialise, dispose of or encumber any interest which it might hold in Project Results outside the Field as it sees fit. (b) Subject to clause 8.1, no Party will deal with, Commercialise, dispose of or encumber any interest which it might hold in Project Results in the Field, except as authorised in this Agreement, or with the written consent of the other Party to this Agreement. (c) Each Party will co-operate with each other Party and promptly do all acts and things and execute all documents which may be necessary for the purpose of vesting ownership of the Project Results in Prana as contemplated by this clause 7.2. (d) Prana grants to NSV, a first right of refusal to negotiate a worldwide exclusive royalty-bearing sub-licensable licence to Commercialise the Project Results in the Field in accordance with clause 8 of this Agreement. (e) As soon as the Project Leaders are notified under clause 9.1(a) of the creation of any Project Results then, if that Project Results alone or together with any Background IP, meets the Project Decision Criteria, the Project Leaders will within 14 days notify all Parties and the Steering Committee in writing that, from the date of notification, NSV may exercise its right of first refusal to license such Project Results and any relevant Background IP and present NSV with sufficient data to make a decision on the exercise of its right of first refusal. -------------------------------------------------------------------------------- Appendix 2.2c of the Research Collaboration Agreement. Page 10 Project Title = Ab binding ligands for imaging of Alzheimer's Disease (AD) 3rd March 2003 Project Agreement Neurosciences Victoria Ltd and Prana Biotechnology Ltd -------------------------------------------------------------------------------- (f) The Parties are aware of the fact that after NSV has received such notification and data in accordance with clause 7.2(e), NSV has the obligation under the RCA to immediately notify SCHERING which has an exclusive right of first negotiation for a sublicence to ail Project Results and Background IP notified to NSV under this Agreement. (g) Under the RCA SCHERING has the right to evaluate the relevant Project Results and Bac...

Project Results. With regard to any other technology and inventions (other than those that are solely specific to the VBI LPV Technology, SVT's Materials or a Project Candidate Vaccine), all rights, title and interest in and to any technology or invention, whether or not patentable, and any patent applications and patents based thereon, made or conceived during the term of this Agreement (i) by employees or others acting solely on behalf of VBI or its Affiliates shall be owned solely by VBI or its Affiliates; (ii) by employees or others acting solely on behalf of SVT or its Affiliates shall be owned solely by SVT or its Affiliates; (iii) by employees, or other acting on behalf, of both VBI and SVT shall be jointly owned (“Joint Invention(s)”). With respect to Joint Invention(s), the parties agree to the following: ● SVT will be in charge of filing maintaining and prosecuting the patent applications related in the name of both parties (costs to be shared by both parties in a 50/50 basis); ● SVT will notify VBI of each country where it intends to file a patent application one(1) month in advance of the filing deadline; if VBI is not interested in having a patent filed in that country, it will promptly inform SVT of that decision, and SVT will then be free to file such patent in that country at its own costs; ● If VBI would like to file in some additional countries, then it will promptly notify SVT, and VBI will then be free to file in such additional countries at its own costs; ● If SVT intends to abandon its rights in a country, it will have then to notify VBI one (1) month in advance, and VBI will then be free to further go on with the prosecution or maintenance at its own costs. Without any answer from VBI within one (1) month of notification, SVT will be free to abandon the patent or patent application. Maintenance and defense of patent rights claiming Joint Inventions will be handled in the License Agreement. Should SVT not exercise its Option, then the Parties agree to enter into a co-ownership agreement. However the Parties already agree and acknowledge that should SVT not exercise its Option, save for the Project Candidate Vaccine, each Party will be entitled to practice and sublicense joint know-how and Joint Inventions without restriction or consent of the other or an obligation to account to the other Party.

Project Results. Project Results shall be Confidential Information of both Parties, except that Clovis Oncology shall have the right to use and disclose Project Results to any Affiliate or Third Party in the Pharmaceutical Field and RMS shall have the right to use and disclose Project Results to any Affiliate or Third Party in the Diagnostics Field.

Project Results. 4.1 All data and information, including Client Inventions as defined under 5.1, arising from the performance of the Services listed in the accepted Project Proposal hereunder, (including but not limited to records, original experimental reports, other material(s) and data), except to the extent such experimental data and information solely relate to the Bioarkive Property (as defined in section 5.2), shall be deemed the intellectual property of Client (“Client Results”). 4.2 Client shall retain title to and shall have the right to publish all Client Results. Client Results shall be retained in the Bioarkive archive in compliance with regulatory and legal requirements or at such archival site as determined by Client at Client’s expense. 4.3 Any and all results generated during or resulting from the Services performed by Bioarkive that solely relate to the Bioarkive Property, shall be deemed the intellectual property of Bioarkive. 4.4 Electronic archival, if available, shall be kept in accordance with the industry standard and in compliance with relevant regulatory and legal requirement. 4.5 To the extent that Services to be performed under a Project Proposal include the development of novel, non-standard preclinical assays for use by Client (each, a "Client-Specific Assay"), each Client-Specific Assay shall be owned by Bioarkive but (a) be licensed exclusively by Bioarkive to Client for use exclusively by or on behalf of Client for a period of three years, and (b) thereafter be licensed non-exclusively by Bioarkive to Client thereafter for use by or on behalf of Client. Such license shall at all times be worldwide, perpectual, irrevocable, royalty-free and fully paid-up.

Project Results. The ownership and use rights of each Party in relation to the Results of a Project shall be agreed between the Parties for each Project and set out in PART 2 – Section 2B – Intellectual Property.